Document Detail


2007 San Diego wildfires and asthmatics.
MedLine Citation:
PMID:  21158525     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
CONTEXT: This case series reports the changes in the respiratory health of eight asthmatic subjects and the relationship with air quality associated with the October 2007 firestorm in San Diego County of California.
CASE PRESENTATION: Participants were eight subjects with asthma enrolled in Asthma Clinical Research Network (ACRN) (NIH# U10-HL074218) studies at the University of California San Diego (UCSD), School of Medicine, who had study data collected immediately prior, during and 1 month after the 5-day firestorm in San Diego County. Air quality deteriorated to an extreme average of 71.5 mg/m(3) small particulate matter less than 2.5 μm (PM(2.5)) during the firestorm. Respiratory health data included morning and evening peak expiratory flow rates (PEFR), morning and evening Forced Expiratory Volume in one second (FEV(1)), rescue medication usage, and sputum eosinophils. Morning and evening PEFR and FEV(1) rates remained stable. The two subjects tested during the fires had elevated eosinophil counts and rescue medication usage was increased in five of the eight subjects.
DISCUSSION: Pulmonary function test values were stable during the wildfires for all eight subjects but there was a statistically significant increase in rescue medication usage during the wildfires that correlated with PM(2.5) values. The two subjects tested during the fires showed increases in sputum eosinophil counts consistent with increased airways inflammation.
RELEVANCE: These findings suggest that poor air quality associated with wildfires resulted in an increase in airways inflammation in these asthmatic subjects, but pulmonary function tests remained stable, possibly due to increased rescue medication usage. This is especially pertinent as there is an increase in incidence of wildfires this decade.
Authors:
Chirag Vora; Marian J Renvall; Peter Chao; Paul Ferguson; Joe W Ramsdell
Related Documents :
15653165 - Cell targeting by a generic receptor-targeted polymer nanocontainer platform.
1999685 - The history of nitrite in human nutrition: a contribution from german cookery books.
19026025 - The afterlife of drugs and the role of pharmecovigilance.
8711095 - Hospitals and plastics. dioxin prevention and medical waste incinerators.
19950315 - Ambulatory visit utilization in a national, population-based sample of adults with oste...
17199145 - Integrating ethics in design through the value-sensitive design approach.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2010-12-15
Journal Detail:
Title:  The Journal of asthma : official journal of the Association for the Care of Asthma     Volume:  48     ISSN:  1532-4303     ISO Abbreviation:  J Asthma     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-01-18     Completed Date:  2011-02-23     Revised Date:  2012-02-02    
Medline Journal Info:
Nlm Unique ID:  8106454     Medline TA:  J Asthma     Country:  England    
Other Details:
Languages:  eng     Pagination:  75-8     Citation Subset:  IM    
Affiliation:
Department of Medicine, School of Medicine, University of California, San Diego, CA, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Albuterol / administration & dosage
Asthma / drug therapy,  physiopathology*
Bronchodilator Agents / administration & dosage
California
Eosinophils / pathology
Fires*
Forced Expiratory Volume
Humans
Particulate Matter / adverse effects*
Peak Expiratory Flow Rate
Sputum / cytology
Grant Support
ID/Acronym/Agency:
U10 HL074218-05/HL/NHLBI NIH HHS; U10-HL074218/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Bronchodilator Agents; 0/Particulate Matter; 18559-94-9/Albuterol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Contraception, reproductive health and pregnancy outcomes among women exposed to intimate partner vi...
Next Document:  HeartMate® II continuous-flow left ventricular assist system.